
    
      This clinical study was a prospective, multi-center, clinical evaluation to document safety
      and effectiveness of the EASYTRAK 3 lead in humans. Patients implanted with the EASYTRAK 3
      lead were followed through pre-discharge, 1-month, 3-month and 6-month follow-ups
    
  